Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Claude Dubray, Philippe Maincent & Jean Yves Milon. (2021) From the pharmaceutical to the clinical: the case for effervescent paracetamol in pain management. A narrative review. Current Medical Research and Opinion 37:6, pages 1039-1048.
Read now
Read now
Nathalie R. Wingert, Natália O. dos Santos, Sarah C. Campanharo, Elisa S. Simon, Nadia M. Volpato & Martin Steppe. (2018) In vitro dissolution method fitted to in vivo absorption profile of rivaroxaban immediate-release tablets applying in silico data. Drug Development and Industrial Pharmacy 44:5, pages 723-728.
Read now
Read now
Ignacio González-García, Victor Mangas-Sanjuán, Matilde Merino-Sanjuán & Marival Bermejo. (2015) In vitro–in vivo correlations: general concepts, methodologies and regulatory applications. Drug Development and Industrial Pharmacy 41:12, pages 1935-1947.
Read now
Read now
Gautam Singhvi, Abhishek Shah, Nilesh Yadav & Ranendra N. Saha. (2015) Prediction of in vivo plasma concentration–time profile from in vitro release data of designed formulations of milnacipran using numerical convolution method. Drug Development and Industrial Pharmacy 41:1, pages 105-108.
Read now
Read now
Jipeng Hou, Xin He, Xuefang Xu, Xiaoyan Shi, Yanyan Xu & Changxiao Liu. (2012) Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro–in vivo correlation. Drug Development and Industrial Pharmacy 38:11, pages 1305-1312.
Read now
Read now
C.G. Wilson, Cyril P. Clarke, Yan Yan L. Starkey & Geoffrey D. Clarke. (2011) Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies. Drug Development and Industrial Pharmacy 37:7, pages 747-753.
Read now
Read now
Adrian Dunne, Clare Gaynor & John Davis. (2005) Deconvolution Based Approach for Level A In Vivo-In Vitro Correlation Modelling: Statistical Considerations. Clinical Research and Regulatory Affairs 22:1, pages 1-14.
Read now
Read now
Yan Wu, D. O. Kildsig & E. S. Ghaly. (2004) Effect of Hydrodynamic Environment on Tablets Dissolution Rate. Pharmaceutical Development and Technology 9:1, pages 25-37.
Read now
Read now
Articles from other publishers (18)
Asami Ono, Rena Kurihara, Katsuhide Terada & Kiyohiko Sugano. (2023) Bioequivalence Dissolution Test Criteria for Formulation Development of High Solubility-Low Permeability Drugs. Chemical and Pharmaceutical Bulletin 71:3, pages 213-219.
Crossref
Crossref
Freja Fredholt, Camilla Di Meo, Stine Sloth, Anette Müllertz & Ragna Berthelsen. (2022) Direct visualizing of paracetamol immediate release tablet disintegration in vivo and in vitro. European Journal of Pharmaceutics and Biopharmaceutics 180, pages 63-70.
Crossref
Crossref
Alok Ranjan & Prateek K. Jha. (2021) Recent Advances in Dissolution Testing and Their Use to Improve In Vitro–In Vivo Correlations in Oral Drug Formulations. Journal of Pharmaceutical Innovation 17:3, pages 1011-1026.
Crossref
Crossref
James Butler & Patrick Augustijns. (2022) An Assessment of Occasional Bio-Inequivalence for BCS1 and BCS3 Drugs: What are the Underlying Reasons?. Journal of Pharmaceutical Sciences 111:1, pages 124-134.
Crossref
Crossref
Bart Hens, Marival Bermejo, Patrick Augustijns, Rodrigo Cristofoletti, Gregory Amidon & Gordon Amidon. (2020) Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics 12:6, pages 566.
Crossref
Crossref
Kiyohiko Sugano. (2016) Theoretical Investigation of Dissolution Test Criteria for Waiver of Clinical Bioequivalence Study. Journal of Pharmaceutical Sciences 105:6, pages 1947-1951.
Crossref
Crossref
David P. Elder, Martin Kuentz & René Holm. (2016) Pharmaceutical excipients — quality, regulatory and biopharmaceutical considerations. European Journal of Pharmaceutical Sciences 87, pages 88-99.
Crossref
Crossref
Barbara A. Wetmore, John F. Wambaugh, Brittany Allen, Stephen S. Ferguson, Mark A. Sochaski, R. Woodrow Setzer, Keith A. Houck, Cory L. Strope, Katherine Cantwell, Richard S. Judson, Edward LeCluyse, Harvey J. Clewell, Russell S. Thomas & Melvin E. Andersen. (2015)
Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted
In Vitro
Bioactivity to Inform Chemical Toxicity Testing
. Toxicological Sciences 148:1, pages 121-136.
Crossref
Crossref
Sarin Colón-Useche, Isabel González-Álvarez, Victor Mangas-Sanjuan, Marta González-Álvarez, Pilar Pastoriza, Irene Molina-Martínez, Marival Bermejo & Alfredo García-Arieta. (2015)
Investigating the Discriminatory Power of BCS-Biowaiver
in Vitro
Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class I Drug
. Molecular Pharmaceutics 12:9, pages 3167-3174.
Crossref
Crossref
H. Kortejärvi, J. Malkki, R. Shawahna, J.-M. Scherrmann, A. Urtti & M. Yliperttula. (2014) Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter. European Journal of Pharmaceutical Sciences 61, pages 18-26.
Crossref
Crossref
Edmund S. Kostewicz, Bertil Abrahamsson, Marcus Brewster, Joachim Brouwers, James Butler, Sara Carlert, Paul A. Dickinson, Jennifer Dressman, René Holm, Sandra Klein, James Mann, Mark McAllister, Mans Minekus, Uwe Muenster, Anette Müllertz, Miriam Verwei, Maria Vertzoni, Werner Weitschies & Patrick Augustijns. (2014) In vitro models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences 57, pages 342-366.
Crossref
Crossref
Kiyohiko Sugano. 2012. Biopharmaceutics Modeling and Simulations. Biopharmaceutics Modeling and Simulations
160
205
.
Stephen Chandler. (2013) Estimation of Onset of Analgesia From Simulated Data: Authors' Response. The Journal of Clinical Pharmacology 52:5, pages 779-779.
Crossref
Crossref
Deirdre M. D’Arcy, Anne Marie Healy & Owen I. Corrigan. (2009) Towards determining appropriate hydrodynamic conditions for in vitro in vivo correlations using computational fluid dynamics. European Journal of Pharmaceutical Sciences 37:3-4, pages 291-299.
Crossref
Crossref
Bertold Renner, Geoff Clarke, Tim Grattan, Angelika Beisel, Christian Mueller, Ulrike Werner, Gerd Kobal & Kay Brune. (2007) Caffeine Accelerates Absorption and Enhances the Analgesic Effect of Acetaminophen. The Journal of Clinical Pharmacology 47:6, pages 715-726.
Crossref
Crossref
Sabah Souliman, Stéphanie Blanquet, Eric Beyssac & Jean-Michel Cardot. (2006) A level A in vitro/in vivo correlation in fasted and fed states using different methods: Applied to solid immediate release oral dosage form. European Journal of Pharmaceutical Sciences 27:1, pages 72-79.
Crossref
Crossref
L. Kalantzi, C. Reppas, J.B. Dressman, G.L. Amidon, H.E. Junginger, K.K. Midha, V.P. Shah, S.A. Stavchansky & Dirk M. Barends. (2006) Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol). Journal of Pharmaceutical Sciences 95:1, pages 4-14.
Crossref
Crossref
A. A. Litvin, G. B. Kolyvanov, V. P. Zherdev & A. P. Arzamastsev. (2004) Relationship between physicochemical characteristics and pharmacokinetic parameters of 1,4-benzodiazepine derivatives. Pharmaceutical Chemistry Journal 38:11, pages 583-586.
Crossref
Crossref